Enfuvirtide | m-entrepreneurship.com

Product Name :
Enfuvirtide

Search keywords :
Enfuvirtide

drugId :
null

Target Vo:
Transmembrane glycoprotein gp41

Target Vo Short Name :
gp41

Moa_Name:
HIV fusion inhibitors

First Approval Country :
United States

First Approval Date Filter:
2003

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :
F. Hoffmann-La Roche Ltd

Active Indication_Name:
HIV Infections

In Active Indication_Name:
Acquired Immunodeficiency Syndrome

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Polatuzumab References
CD44 Rabbit mAb Biological Activity
BMP2 Antibody: BMP2 Antibody is an unconjugated, approximately 13/44 kDa, rabbit-derived, anti-BMP2 polyclonal antibody. BMP2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts